1.08
price down icon2.26%   -0.025
 
loading
전일 마감가:
$1.105
열려 있는:
$1.1
하루 거래량:
45,839
Relative Volume:
0.02
시가총액:
$4.82M
수익:
$72,100
순이익/손실:
$-3.60M
주가수익비율:
-0.9076
EPS:
-1.19
순현금흐름:
$-3.37M
1주 성능:
-13.60%
1개월 성능:
-13.25%
6개월 성능:
+1.89%
1년 성능:
-45.23%
1일 변동 폭
Value
$1.01
$1.10
1주일 범위
Value
$1.01
$1.2333
52주 변동 폭
Value
$0.77
$4.50

Silo Pharma Inc Stock (SILO) Company Profile

Name
명칭
Silo Pharma Inc
Name
전화
(718) 400-9031
Name
주소
677 N. WASHINGTON BLVD, SARASOTA
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
SILO's Discussions on Twitter

SILO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
 icon
SILO
SILO PHARMA INC
1.71 17.96M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
19.95 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.16 304.74M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.265 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.25 142.54M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
10.50 141.55M 0 0 0 0.00

Silo Pharma Inc 주식(SILO)의 최신 뉴스

pulisher
Mar 31, 2025

Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Increases By 38.7% - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Silo Pharma Inc. (SILO) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

Silo Pharma, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

SILO Stock Price and Chart — NASDAQ:SILO - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

Silo Pharma begins key study for PTSD treatment By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Doses First Participant In IND-Enabling GLP Study Of SPC-15 For PTSD Treatment - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma begins key study for PTSD treatment - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone With First Dosing In IND-Enabling GLP Study For SPC-15 As A Groundbreaking PTSD Treatment - Marketscreener.com

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

Silo Pharma Achieves Key Milestone with First Dosing in - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Major PTSD Treatment Advance: FDA Fast-Track Path Opens for Revolutionary Drug SPC-15 - Stock Titan

Mar 26, 2025
pulisher
Mar 10, 2025

Silo Pharma Unveils Strategic Initiatives and Drug Pipeline - TipRanks

Mar 10, 2025
pulisher
Mar 07, 2025

Silo Pharma secures patent for stress disorder prophylactic - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Silo Pharma secures patent for stress disorder prophylactic By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Feb 27, 2025

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

MarketsMedicine Hat News - Financial Content

Feb 27, 2025
pulisher
Feb 26, 2025

Silo Pharma Granted US Patent for Intranasal Post-Traumatic Stress Disorder Treatment - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Silo Pharma, Inc. Receives Issuance Notification for Patent Related to SPC-15 Treatment for PTSD - Nasdaq

Feb 26, 2025
pulisher
Feb 18, 2025

Silo Files Provisional Patent For SPC-15 Combination Treatment To Target Stress-Induced Disorders - Nasdaq

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment - The Manila Times

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with - GlobeNewswire

Feb 18, 2025
pulisher
Feb 18, 2025

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for ... - The Bakersfield Californian

Feb 18, 2025
pulisher
Feb 18, 2025

Revolutionary Mental Health Treatment Patent: Silo Pharma's Dual-Action SPC-15 Shows Promising Results - StockTitan

Feb 18, 2025
pulisher
Feb 12, 2025

Silo Pharma reports positive early data on pain treatment implant By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma reports positive early data on pain treatment implant - Investing.com

Feb 11, 2025
pulisher
Feb 11, 2025

SILO’s valuation metrics: A comprehensive analysis - US Post News

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma's SP-26 Shows Promising Initial Safety And Absorption Data For Pain Relief - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma Reports Positive Safety Update from SP-26 Ketamine Implant Study with No Serious Side Effects Observed - Nasdaq

Feb 11, 2025
pulisher
Feb 11, 2025

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 - The Bakersfield Californian

Feb 11, 2025
pulisher
Feb 11, 2025

Revolutionary Pain Treatment: SILO's Ketamine Implant Aces Initial Safety Tests - StockTitan

Feb 11, 2025
pulisher
Feb 04, 2025

Monitoring SILO Pharma Inc (SILO) after recent insider movements - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

SILO Pharma Inc (SILO) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

SILO Pharma Inc’s Market Journey: Closing Strong at 1.79, Up 11.18 - The Dwinnex

Feb 04, 2025
pulisher
Jan 23, 2025

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment - GlobeNewswire

Jan 23, 2025
pulisher
Jan 22, 2025

Silo Pharma files provisional patent for PTSD treatment - MSN

Jan 22, 2025
pulisher
Jan 22, 2025

Silo Pharma Files Breakthrough PTSD Treatment Patent, Expands Columbia Tech Portfolio - StockTitan

Jan 22, 2025
pulisher
Jan 15, 2025

Looking For A Good Stock? Let This SILO Pharma Inc (NASDAQ: SILO) Analysis Help. - Stocks Register

Jan 15, 2025
pulisher
Jan 13, 2025

After A Patent Win, Analysts Think This Penny Stock Can Gain 465% In 2025 - Barchart

Jan 13, 2025
pulisher
Jan 10, 2025

Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 10, 2025
pulisher
Jan 09, 2025

Silo Pharma awarded U.S. patent for PTSD treatment - Yahoo Finance

Jan 09, 2025
pulisher
Jan 09, 2025

Silo Pharma secures patent for PTSD intranasal treatment By Investing.com - Investing.com Nigeria

Jan 09, 2025
pulisher
Jan 08, 2025

SILO Pharma flies high on impending patent for intranasal PTSD drug - Mugglehead

Jan 08, 2025
pulisher
Jan 08, 2025

Crude Oil Down 1%; US Weekly Jobless Claims Decline - Benzinga

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma shares soar on patent allowance news By Investing.com - Investing.com South Africa

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma shares soar on patent allowance news - Investing.com India

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma secures patent for PTSD intranasal treatment - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

Silo Pharma Secures Key Patent Protection for PTSD Treatment SPC-15, Strengthens IP Portfolio - StockTitan

Jan 08, 2025

Silo Pharma Inc (SILO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Silo Pharma Inc 주식 (SILO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Weisblum Eric
CEO and President
Nov 20 '24
Buy
0.95
2,500
2,375
182,932
Weisblum Eric
CEO and President
Nov 22 '24
Buy
0.90
2,500
2,250
185,432
Weisblum Eric
CEO and President
Jun 12 '24
Buy
1.11
4,438
4,926
180,432
Weisblum Eric
CEO and President
Jun 11 '24
Buy
1.08
562
607
175,994
Weisblum Eric
CEO and President
Apr 05 '24
Buy
2.03
400
812
175,432
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):